UKBizDB.co.uk

TYG ONCOLOGY LTD.

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Tyg Oncology Ltd.. The company was founded 11 years ago and was given the registration number 08378440. The firm's registered office is in MANSFIELD. You can find them at Synergy House 7 Acorn Business Park, Commercial Gate, Mansfield, Nottinghamshire. This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:TYG ONCOLOGY LTD.
Company Number:08378440
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:28 January 2013
End of financial year:31 March 2023
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:Synergy House 7 Acorn Business Park, Commercial Gate, Mansfield, Nottinghamshire, NG18 1EX
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Mansfield I Centre, Hamilton Way, Mansfield, England, NG18 5BR

Director21 May 2013Active
24, Buckingham Road, Sandiacre, Nottingham, United Kingdom, NG10 5PP

Director28 January 2013Active
Krottenbachstrasse, 106/8/9, 1190 Wien, Austria,

Director27 October 2014Active
Hochmayrstrasse 31, 2384, Breitenfurt Bei Wien, Austria,

Director27 October 2014Active

People with Significant Control

Oncoqr Ml Gmbh
Notified on:06 April 2016
Status:Active
Country of residence:Austria
Address:Walterstrasse 21, 3011, Tullnerbach, Austria,
Nature of control:
  • Ownership of shares 25 to 50 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (0 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (2 months remaining)

Copyright © 2025. All rights reserved.